✦ LIBER ✦

P.233 RETREATMENT WITH PEG-IFN ALPHA-2A PLUS RIBAVIRIN FOR 48 WEEKS IN CHRONIC HEPATITIS C GENOTYPE 2 AND 3 RELAPSERS TO A PREVIOUS ANTIVIRAL TREATMENT

✍ Scribed by E. Minola; V. Baldo; T. Baldovin; A. Floreani

Book ID: 119633941
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 58 KB
Volume: 42
Category: Article
ISSN: 1590-8658
DOI: 10.1016/s1590-8658(10)60345-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

280 RETREATMENT WITH PEG-IFN ALPHA-2A PL

280 RETREATMENT WITH PEG-IFN ALPHA-2A PLUS RIBAVIRIN FOR 48 WEEKS IN CHRONIC HEPATITIS C GENOTYPE 2 AND 3 RELAPSERS TO A PREVIOUS ANTIVIRAL TREATMENT

✍ E. Minola; V. Baldo; T. Baldovin; A. Floreani 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 70 KB

Retreatment with pegylated interferon-al

Retreatment with pegylated interferon-alpha2b plus ribavirin in patients with chronic hepatitis C not responding to a previous antiviral treatment with standard interferons combined with ribavirin

✍ Teuber, Gerlinde; Kallinowski, Birgit; Niederau, Claus; Klinker, Hans; Galle, Pe 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 243 KB

Controlled trial with pegylated interfer

Controlled trial with pegylated interferon-alpha2b plus ribavirin retreatment in patients with chronic hepatitis C not responding to a previous antiviral treatment with standard interferons combined with ribavirin

✍ G. Teuber; B. Kallinowski; C. Niederau; H. Klinker; P.R. Galle; M. Zankel; S. Ze 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 163 KB

High dose IFN-A2b induction followed by

High dose IFN-A2b induction followed by IFN plus ribavirin combination in patients with chronic hepatitis C who were relapsers to previous IFN treatment. A randomized placebo-controlled study

✍ Ganger, Daniel R.; Conjeevaram, Hari; Wiley, Thelma E.; Flamm, Steven L.; O’Rior 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 184 KB

[779] ANTIVIRAL RESPONSE AT WEEK 12 FOLL

[779] ANTIVIRAL RESPONSE AT WEEK 12 FOLLOWING COMPLETION OF TREATMENT WITH ALBINTERFERON a-2b PLUS RIBAVIRIN IN GENOTYPE 1, IFN-NAIVE, CHRONIC HEPATITIS C PATIENTS

✍ S. Zeuzem; Y. Benhamou; V. Bain; D. Shouval; S. Pianko; R. Flisiak; M. Grigoresc 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 133 KB

Weight affect relapse rates in latinos w

Weight affect relapse rates in latinos with genotype 2/3 chronic hepatitis C (CHC) treated with peg IFN alfa-2a (Pegasys) 180 mcg/week and 800 mg daily of ribavirin for 24 weeks

✍ Maribel Rodríguez-Torres; Carlos F. Ríos-Bedoya; Grisell Ortiz-Lasanta; Dagmary 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB

## Abstract Efficacy of chronic hepatitis C (CHC) treatment with Peg‐IFN and Ribavirin (RBV) is superior for genotypes 2/3 (GT‐2/3) than for genotype 1 (GT‐1) patients. Efficacy of treatment in Latinos infected with GT‐2/3 is unknown. The purpose of the study was to examine efficacy of Peg‐IFN/RBV